Hypoalbuminaemia after prolonged treatment with recombinant granulocyte macrophage colony stimulating factor
- PMID: 2271856
- PMCID: PMC1664465
- DOI: 10.1136/bmj.301.6764.1312-a
Hypoalbuminaemia after prolonged treatment with recombinant granulocyte macrophage colony stimulating factor
Similar articles
-
Granulocyte colony-stimulating factors.Med Lett Drugs Ther. 1991 Jun 28;33(847):61-3. Med Lett Drugs Ther. 1991. PMID: 1710761 No abstract available.
-
Phase II study of recombinant human granulocyte-macrophage colony-stimulating factor in myelodysplastic syndrome and aplastic anemia.Acta Haematol. 1993;89(4):189-94. doi: 10.1159/000204521. Acta Haematol. 1993. PMID: 8212999 Clinical Trial.
-
Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in patients with aplastic anemia and refractory anemia.Stem Cells. 1994 Nov;12(6):604-15. doi: 10.1002/stem.5530120608. Stem Cells. 1994. PMID: 7533579 Clinical Trial.
-
Clinical trials of granulocyte-macrophage colony-stimulating factor for the treatment of aplastic anemia.Immunol Ser. 1992;57:661-70. Immunol Ser. 1992. PMID: 1504150 Review. No abstract available.
-
[Advances in the research of clinical use of recombinant human granulocyte colony-stimulating factors].Zhonghua Nei Ke Za Zhi. 1991 Nov;30(11):723-5. Zhonghua Nei Ke Za Zhi. 1991. PMID: 1726145 Review. Chinese. No abstract available.
Cited by
-
Treatment of neutropenia in Felty's syndrome with granulocyte-macrophage colony-stimulating factor--hematological response accompanied by pulmonary complications with lethal outcome.Ann Hematol. 1992 Nov;65(5):232-5. doi: 10.1007/BF01703951. Ann Hematol. 1992. PMID: 1457582
-
Clinical toxicity of cytokines used as haemopoietic growth factors.Drug Saf. 1995 Dec;13(6):371-406. doi: 10.2165/00002018-199513060-00006. Drug Saf. 1995. PMID: 8652081 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources